Skip to main content

Table 1 Interventions: administration methods and duration in the experimental and control group

From: Clinical efficacy of Tailin formulation combined with continuous low-dose antimicrobial therapy for recurrent urinary tract infection: study protocol for a multicenter, double-blind, randomized, controlled clinical trial

Treatment

Time

Week 0–2

Week 3–4

Week 5–6

Week 7–8

Week 9–10

Week 11–12

TLF

○

○

○

○

○

○

Placebo

●

●

●

●

●

●

CLAT

 

Levofloxacin

(0.1 g, QN, po)

○●

 

○●

 

Nitrofurantoin

(0.1 g, QN, po)

 

○●

 

○●

 

Cefdinir

(0.1 g, QN, po)

 

○●

 

○●

  1. A white circle represents the treatment of the treatment group; a black circle represents the treatment of the control group
Back to article page

Trials

ISSN: 1745-6215